Articles On Adalta (ASX:1AD)

Here’s our fortnightly wrap of all the news driving ASX small cap health stocks. We last checked in with ASX small cap health stocks just hours after Opthea’s (ASX:OPT) anti macular degeneration drug passed a large clinical test with flying...

Stockhead’s Top 10 at 10 highlights the best (and the worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (e...

As per the announcements on ASX, all the six stocks have released updates on changes in directors’ interest, appointment/resignation/retirement from the Board and changes in the shareholding. Let us now have a detailed look at the updates...

AdAlta (ASX: 1AD), an Australian biotechnology company on its lead i-body therapeutic AD-214 for human clinical trials for Idiopathic Pulmonary Fibrosis, has appointed Dr Rosalind Wilson to the role of non-executive director.

Healthcare Healthcare sector comprises of the companies that offer medical services, producing medical equipment or medicines. These companies also give medical insurance to the patients. In Australia, the funding of healthcare is taken ca...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...